Temporal activity of plasminogen activators and matrix metalloproteinases during cutaneous wound repair.

[1]  P. Basset,et al.  Expression of Matrix Metalloproteinases during Rat Skin Wound Healing: Evidence that Membrane Type-1 Matrix Metalloproteinase Is a Stromal Activator of Pro-Gelatinase A , 1997, The Journal of cell biology.

[2]  I. K. Cohen,et al.  Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. , 1996, The Journal of investigative dermatology.

[3]  J. Kere,et al.  Patterns of matrix metalloproteinase and TIMP‐1 expression in chronic and normally healing human cutaneous wounds , 1996, The British journal of dermatology.

[4]  W. Stetler-Stevenson,et al.  Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.

[5]  A. Vaheri,et al.  Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. , 1996, The Journal of investigative dermatology.

[6]  R. Langer,et al.  Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing , 1996, Journal of cellular biochemistry.

[7]  P. Libby,et al.  Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  D. Heimbach,et al.  Basic fibroblast growth factor in the early human burn wound. , 1994, The Journal of surgical research.

[9]  H. Larjava,et al.  Expression of matrix metalloproteinase-2 and -9 during early human wound healing. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[10]  F. Grinnell,et al.  Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. , 1993, The Journal of investigative dermatology.

[11]  A. Mazar,et al.  Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. , 1992, The Journal of biological chemistry.

[12]  L. Lund,et al.  Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. , 1991, The Journal of investigative dermatology.

[13]  L. Orci,et al.  Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene , 1990, Cell.

[14]  D. Greenhalgh,et al.  PDGF and FGF stimulate wound healing in the genetically diabetic mouse. , 1990, The American journal of pathology.

[15]  J. Potempa,et al.  Alpha-2-antiplasmin: a serpin with two separate but overlapping reactive sites. , 1988, Science.

[16]  L. Nelles,et al.  Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity. , 1987, Science.

[17]  M J Banda,et al.  Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. , 1986, The Journal of biological chemistry.

[18]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[19]  L. Orci,et al.  Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. , 1996, Enzyme & protein.

[20]  D. Rifkin,et al.  Plasminogen activators and matrix metalloproteinases in angiogenesis. , 1996, Enzyme & protein.

[21]  M. Cubellis,et al.  The receptor for urokinase‐plasminogen activator , 1986, Journal of cellular biochemistry.